alpha-1, 5%; alpha-2, 18%; beta, 16%; gamma, 19%); serum creatinine, 0.7 mg/dl; sodium, 135 mEq/liter; potassium, 4.2 mEq/liter; chloride, 96 mEq/liter; bicarbonate, 26 mEq/liter; and glucose, 106 mg/dl. Liver function tests were normal. A 24-hour urine collection contained 10 g protein. The urinary sediment showed 100,000 red blood cells/ml. Immunologic tests were negative, except for the presence of antinuclear antibodies (1:1000) but without anti-DNA antibodies. Ultrasonography revealed no abdominal abnormality and two normal-sized kidneys.
alpha-1, 5%; alpha-2, 18%; beta, 16%; gamma, 19%); serum creatinine, 0.7 mg/dl; sodium, 135 mEq/liter; potassium, 4.2 mEq/liter; chloride, 96 mEq/liter; bicarbonate, 26 mEq/liter; and glucose, 106 mg/dl. Liver function tests were normal. A 24-hour urine collection contained 10 g protein. The urinary sediment showed 100,000 red blood cells/ml. Immunologic tests were negative, except for the presence of antinuclear antibodies (1:1000) but without anti-DNA antibodies. Ultrasonography revealed no abdominal abnormality and two normal-sized kidneys.
A renal biopsy was performed. Light microscopic examination (Fig. 1A) showed only hypertrophy of some podocytes. The capillary walls had a nearly normal appearance. Immunofluorescent examination revealed, however, typical subepithelial deposits brightly stained with anti-␥ (Fig. 1B) , anti-, and anti-antibodies. Droplets of polyclonal IgG and IgA also were
CASE PRESENTATIONS
seen in the cytoplasm of proximal tubules. Electron microscopy Patient 1. A 49-year-old white man was referred to the confirmed the presence of small, granular, electron-dense deRenal Division at Hô pital Tenon for investigation of nephrotic posits on the outer aspect of the glomerular capillary basement syndrome in the setting of bronchogenic carcinoma. Past medimembrane. cal history was unremarkable, except for two urinary tract One week after biopsy, the patient was randomized after infections; an intravenous pyelogram performed six months informed consent into the chemotherapy arm of a French proearlier had been normal. Three months before admission, anetocol for the treatment of bronchogenic carcinoma. He received mia had been discovered together with an inflammatory syna single course of chemotherapy without corticosteroid (mitodrome. The patient had recently lost 6 kg. He also complained mycin, 6 mg/m 2 at day one; cisplatin, 30 mg; and ifosfamide, of cough of recent onset, although he had a 25-pack-year history 1.5 mg/m 2 from day one to day three), followed one month of cigarette smoking. A chest radiograph revealed a dense later by surgery. Pre-operative staging showed a 50% reduction opacity of the right lung apex. A CT scan showed that this of the tumor mass but the persistence of high urinary protein mass was located in the apico-dorsal segment of the right upper excretion (7 g/day). Thoracotomy revealed a 7 cm in diameter lobe and was associated with enlarged lymph nodes and a neoplastic mass without signs of lymph node invasion and mepleural reaction. Bronchoscopy disclosed a necrotic tumor in tastasis (stage T2, N0, M0). The patient then received three the posterior and apical apertures of the right upper bronchus.
additional courses of the same chemotherapy regimen at oneBronchial biopsies established a diagnosis of epidermoid bronchogenic carcinoma. month intervals. On admission, the patient looked tired and pale. His blood A 24-hour urine collection contained 7 g protein eight days pressure was 120/80 mm Hg. Physical examination was normal, after total excision of the carcinoma, but proteinuria totally showing neither edema nor signs of tumor dissemination. Labodisappeared within two months. It did not recur when the ratory tests showed: hemoglobin, 12.4 g/dl; erythrocyte sedipatient presented five months after surgery with a mediastinal mentation rate, 86 mm/hr; total protein, 5.6 g/dl (albumin, 42%; lymph node relapse, which was controlled by cobalt therapy. Three years after surgery, the patient is doing well, without either proteinuria or other manifestation of tumor recurrence. mobile lymph nodes in the right cervical and both inguinal either by immunofluorescence or by electron microscopy along tubular basement membranes. Mesangial interposition was areas, without liver and spleen enlargement.
Laboratory investigation revealed: BUN, 36 mg/dl; serum seen in rare lobules. A diagnosis of immunotactoid glomerulonephritis with monotypic IgG deposits was made. creatinine, 1.4 mg/dl; total protein, 6.7 g/dl; albumin, 3.7 g/dl; hematocrit, 37%; cholesterol, 9.6 mmol/liter; and triglycerides, Chlorambucil and prednisone were continued for three years, during which time the renal disease was well controlled. 1.78 mmol/liter. Hemoglobin was 12.3 g/dl. The white blood cell count was 14.2 ϫ 10 6 /ml with 70% lymphocytes. The plateThe patient died from sepsis. Patient 3. A 58-year-old white man was referred to the Relet count was 36 ϫ 10 6 /ml. The 24-hour urinary protein excretion was 8 g, with 79% albumin. The urinary sediment connal Division of Chartres Hospital (Chartres, France) for evaluation of edema. His medical record mentioned the detection of tained numerous red blood cells (450,000/ml) but no white cells. Urine culture showed no growth. Immunologic studies hematuria a few years earlier during a routine checkup and the recent onset of hypertension. disclosed hypogammaglobulinemia (0.5 g/dl) due to a decreased level of IgG (0.3 g/dl), and transient signs of compleClinical examination revealed a blood pressure of 170/100 mm Hg and edema of the legs. Laboratory tests showed a ment consumption (CH 50 , 33%). No monoclonal component was found in either the serum or the urine, and repeated hemoglobin of 12.7 g/dl, a white blood cell count of 6.3 ϫ 10 6 /ml, and a platelet count of 290 ϫ 10 6 /ml. Total serum protein searches for cryoglobulinemia were negative. A bone marrow biopsy revealed diffuse infiltration by apparently normal, small was 3.2 g/dl, serum creatinine was 1.2 mg/dl, and glycemia was in the normal range. Proteinuria was only 1.0 g/day. Liver lymphocytes. Numerous megakaryocytes were seen; a search for anti-platelet antibodies was negative. Typing of blood function tests were normal. Because of marked hypoalbuminemia (2.3 g/dl), tests for protein-losing enteropathy and mallymphocytes showed 65% B-and 20% T-lymphocytes. Chest radiographs were normal. Ultrasonography revealed two norabsorption were performed. All were negative, as was the search for amyloid deposits in gastrointestinal biopsies. Hemamal-sized kidneys, but no lymph node or liver enlargement. However, lymphography disclosed diffuse, heterogeneous turia was present; there were 40,000 to 200,000 cells/ml. Serum electrophoresis showed hypogammaglobulinemia (IgG, 0.23 nodes without signs of lymphatic obstruction.
A diagnosis of CLL-related glomerulopathy was made, but g/dl; IgA, 0.19 g/dl; IgM, 0.035 g/dl), and immunoelectrophoresis disclosed a monoclonal IgG in the serum and free light a renal biopsy could not be performed because of thrombocytopenia. The patient then received 12 courses of chemotherapy chains in the urine. The C3 and C4 complement levels were in the normal range. Searches for cryoglobulinemia were fruitincluding cyclophosphamide, adriamycin, vincristine, and prednisone over a period of 18 months. Under this regimen, proteinless. A bone-marrow aspirate contained 14% dystrophic plasma cells, consistent with multiple myeloma. Skeletal radiographs uria decreased to less than 2 g/day, renal function improved (serum creatinine, 1.0 mg/dl), and abdominal lymph nodes disdid not reveal osteolytic lesions. A renal biopsy was performed. Light microscopic examinaappeared on lymphography, as did blood lymphocytosis. The white blood cell count was 4 ϫ 10 6 /ml with 31% lymphocytes tion showed nodular glomerulosclerosis with a marked increase in mesangial matrix and irregular thickening of glomerular at the end of chemotherapy, but the platelet count remained low, between 63 and 76 ϫ 10 6 /ml. The patient was given nine basement membranes (Fig. 3A) . Mesangial nodules were stained with periodic acid Schiff. Only mild, focal thickening of tubular courses of chlorambucil and prednisone over a one-year period. For the first time, the platelet count increased above 100 ϫ basement membranes was present. No evidence of amyloid was seen. Electron microscopy disclosed an expanded mesangial 10 6 /ml, and the patient was referred to our Renal Division for a renal biopsy. matrix with deposition of finely granular, electron-dense material within mesangial nodules. Glomerular basement membranes On physical examination, the patient looked healthy. He had no functional complaints or clinical abnormalities. Laboratory were irregularly thickened, due to a continuous band of granular, electron-dense material located in the lamina rara interna studies showed 3.6 ϫ 10 6 /ml white blood cells with 35% lymphocytes and 110 ϫ 10 6 /ml platelets; hemoglobin, 12.2 g/dl; total and/or in the lamina densa; this thickening often resulted in dense transformation of the whole basement membrane (Fig.  protein, 5 .2 g/dl (albumin, 70%; alpha-2, 10%; gamma globulins, 8%); creatinine, 0.7 mg/dl; creatinine clearance, 76 ml/ 3B). By immunofluorescence, mesangial nodules and glomerular basement membranes were heavily stained with the anti-␥ min; normal liver function tests; and no cryoglobulin. Daily urinary protein output had increased slightly (2 to 3 g/day), heavy chain conjugate (Fig. 4) , but no staining was observed with the anti-or the anti-polyclonal and monoclonal antibut the urinary sediment was normal. A bone marrow aspirate showed only 10% lymphocytes with a normal distribution of bodies. In addition, a faint staining of some tubular and vascular structures was visible with the anti-␥ heavy-chain antibody. granular cells. No monoclonal component was detected in the serum or the urine by sensitive immunofixation techniques.
Furthermore, by using monoclonal antibodies specific for the ␥ heavy-chain constant domains, we found that the deposited However, a few blood cells showed cytoplasmic spots of ␥ and chains by immunofluorescence. heavy chain belonged to the ␥1 subclass and lacked the C H 1 domain (Fig. 4) . The heavy chain in the circulating monoclonal A renal biopsy showed an atypical membranous glomerulonephritis. Capillary walls were thickened and irregular, with IgG was also a C H 1-deleted ␥1 chain. Bone marrow studies (J.C. Brouet, Hô pital Saint-Louis, Paris) were consistent with numerous spikes after silver methenamine staining ( Fig. 2A) . Four atypical features were noted, however. First, foci of mesthe synthesis of a short ␥ heavy chain and normal-sized chains, which partly assembled covalently as half immunoglobangial hypertrophy and cellular proliferation were visible ( Fig.  2A) . Second, the interstitium contained lymphocytic infiltrates.
ulin molecules (composed of one and one short ␥ chain). A diagnosis of myeloma-induced heavy chain deposition disease Third, immunofluorescent examination disclosed granular monotypic IgG deposits on the outer aspect of capillary walls was made.
The patient was subsequently begun on a chemotherapy (Figs. 2B-C), contrasting with the lack of circulating IgG by immunoelectrophoresis and immunofixation. Fourth, electron regimen including vincristine, melphalan, cyclophosphamide, and prednisone, administered on a monthly basis for one year. microscopic evaluation disclosed that these subepithelial deposits had a fibrillary structure (Fig. 2D) . They consisted of During that time, his proteinuria disappeared, serum albumin returned to normal, and renal function remained stable. A microtubules with a diameter of 22 nm. There were no deposits Monoclonal antibodies specific for ␥-chain constant domains and for ␥1 heavy-chain were used. Deposits reacted with NL16, a monoclonal antibody specific for the ␥1 subclass. Note staining of the deposits with anti-C H 2 and anti-C H 3 antibodies but not with the anti-C H 1 antibody (original magnification ϫ 312).
second renal biopsy showed significant improvement of the lar link, and even specific molecular abnormalities, can renal lesions. The patient's treatment was then shifted to interbe demonstrated in lymphoplasmacytic disorders.
feron ␣ (9 ϫ 10 6 units/week).
The concept of paraneoplastic glomerulopathy was . These studies highlighted the high prevalence emplify the heterogeneity of this disease. Diverse glomerof MGN (34%) and minimal change disease (MCD, ular lesions occur in a variety of neoplasms; I will discuss 24%); the former was observed in 68% of the patients several different pathophysiologic links between the glowith a carcinoma, the latter in 50% of those with Hodgmerulopathy and the cancer. The order of presentation of kin's disease. Other types of glomerular lesions were the cases reflects our increasing level of pathophysiologic described in this series and in more recent reports, inknowledge: whereas the pathophysiology of solid-tumorassociated glomerulopathies remains obscure, a molecucluding IgA nephropathy and Henoch-Schö nlein pur- dence of cancer in their population of 128 MGN patients limited to mesangial hypertrophy, and no epimembrawas about 10 times higher than that observed in agenous deposits were noted. matched controls [20] . However, it is intriguing that In two clinical series, the prevalence of renal involvesubepithelial deposits were not found or were found very ment was low [6, 7] . Urinary protein excretion greater infrequently in autopsy series of cancer patients [4, 5; than 100 mg/liter and hematuria were detected in 10% reviewed in 21]. and 7%, respectively, of 600 patients with bronchial carTheoretically, the diagnosis of paraneoplastic glomercinoma [6] . In another study [7] , proteinuria greater than ulopathy should rely on three strong criteria. First, a 0.1 g/liter was more common in patients with malignanclinical and histologic remission occurs after complete cies (174/504, 34%) than in control patients (39/529, 7%).
surgical removal of the tumor or chemotherapy-induced Median urinary protein concentrations were 0.14 (0.07 complete remission of the disease. However, relatively to 0.29) g/liter in the former, and 0.07 (0.05 to 0.12) g/liter few papers have reported remission of MGN following in the latter. However, the rates of renal manifestations removal of a solid tumor [reviewed in 19] . This finding in these studies overestimate the actual prevalence of probably is due to the fact that the majority of carcinoparaneoplastic glomerulopathies for at least three reamas associated with MGN are surgically incurable at sons. First, the threshold of proteinuria selected by the presentation. Moreover, in patients showing remission authors was quite low, within the range of physiologic of the nephrotic syndrome, like Patient 1, histologic cure proteinuria. Second, hematuria was detected by qualitaof the glomerulopathy is usually not verified by a renal tive dipstick tests only, without quantitation of the uribiopsy for ethical reasons. Thus, one cannot exclude nary sediment. Third, paraneoplastic glomerulopathies spontaneous remission of the nephrotic syndrome deare not the only cause of urinary abnormalities in cancer spite persistent subepithelial membranous deposits. I patients (Table 1) .
should stress that spontaneous remission of the nephrotic Conversely, the prevalence of cancer in patients with syndrome occurs in about 30% of patients presenting glomerulopathies is easier to establish (Table 2) . Cancer with idiopathic MGN within one year of follow up [22] . occurs in 11% to 13% of patients with the nephrotic Second, a renal relapse accompanies recurrence of the syndrome [2, 8] . Depending on the age of the patients neoplasia. In other words, proteinuria should directly and the type of glomerular lesions, cancer rates can reach correlate with tumor activity. In fact, the course of cancer as high as 22% in patients over the age of 60 presenting and glomerulopathy can be dissociated, as in the first patient, who presented with a mediastinal lymph node with MGN [8]. Although it is generally agreed that a search for maligbeen reported so far, however. Alpers and Cotran consequently have suggested that the association between manancy is warranted in all patients presenting with apparently idiopathic MGN, particularly those over the age lignancy and MGN has been overemphasized [21] .
In patients in whom the diagnosis of paraneoplastic of 50, the extent of the workup remains controversial. I believe that in addition to a thorough history of the MGN is likely because of a clear temporal relationship between MGN and malignancy, the following features patient with a search for personal and hereditary cancer risk factors, physical examination, and standard biologic of the renal disease are notable. Compared to idiopathic forms, paraneoplastic MGNs are characterized by a tests, one should undertake basic routine cancer screening procedures, including a chest radiograph and a fleximarked male preponderance, mean age over 50, and a full-blown nephrotic syndrome always present. Of the ble colonoscopy. Further investigation, including flexible bronchoscopy or gastroscopy and CT scan, might be in patients with carcinoma and MGN, 40% to 45% clinically manifest the nephrotic syndrome prior to the diagorder after this first-line evaluation. More important, these patients should be closely followed, as the malignosis of their tumor. Simultaneous presentation occurs in about 40% of patients, and in the remaining 15% to nancy could be occult and not detectable on initial routine screening. 20%, renal disease becomes apparent following diagnosis of their tumor. In the majority of cases, the two proOther carcinoma-associated glomerulopathies. Membranous glomerulonephritis is not the only paraneoplascesses manifest themselves within 12 months of each other [2, 3, 13, 18, 19]. The renal lesions are similar to tic glomerulopathy (Table 2 ). Other varieties include
IgA nephropathy, crescentic glomerulonephritis, memtions is too small (Ͻ20) for one to conclude that a causal relationship exists betweeen carcinoma and the renal branoproliferative glomerulonephritis (MPGN), and minimal-change disease (MCD). The IgA nephropathies dedisease [reviewed in 26, 27] . Carcinoma-associated amyloidosis deserves special serve special comment. These lesions can be limited to the kidney or associated with Henoch-Schö nlein purdiscussion. Approximately 3% of renal cell carcinomas are associated with AA-type amyloidosis [reviewed in pura; one should suspect paraneoplastic IgA nephropathy if the patient has necrotic skin lesions in the absence 28]; this systemic complication not only causes the nephrotic syndrome, but also liver and spleen involvement. of cryoglobulin. Of 26 patients aged 60 or older, 6 (23%) had an intercurrent malignancy in Mustonen et al's seOf all carcinomas associated with amyloidosis, 25% to 33% are renal cell carcinomas, yet this tumor accounts ries, whereas none of the 158 patients under age 60 had cancer (Table 2 ) [17] . Any IgA nephropathy in a patient for only 2% to 3% of all carcinomas. The production of IL-6 by renal tumor cells could account for the fever over age 60 should prompt a search for a solid tumor, particularly in the respiratory tract, the buccal cavity, and and chronic inflammation frequently observed in these patients. Remission of the nephrotic syndrome can occur the (naso)pharynx [17] . This association can, however, be fortuitous or be strengthened by alcoholism, which is a following nephrectomy. Renal amyloid deposits, however, seem more persistent than are liver and spleen risk factor for both hepatopathy-induced IgA nephropathy and cancers of the upper respiratory tract. Pathophysiology of paraneoplastic glomerulopathies in carcinoma patients. Now I would like to discuss the pathocells raises the level of circulating IgA and possibly produces mesangial IgA deposits [17] .
genesis of paraneoplastic glomerulopathies with granular immune deposits, mainly membranous glomerulopathy. Several reports strongly suggest an association between rapidly progressive glomerulonephritis and carciDespite considerable efforts in many laboratories, including ours, identification of the human antigens implinoma (and lymphoplasmacytic disorders); the prevalence of cancer was 7% to 9% in patients with a pathologic cated in primary (idiopathic) membranous glomerulopathies has been unsuccessful. Although megalin, the target diagnosis of crescentic glomerulonephritis (Table 2) [15, 16] . In four of the seven patients reported by Biava et antigen of Heymann's nephritis-a faithful model of membranous nephropathy in the rat-is expressed on al, renal function improved following treatment of the underlying malignancy, which only consisted of surgery the brush border of the human proximal tubule, it is not detected on the human podocyte [30] . Megalin thus and/or irradiation in three of them [16] . In most instances, as in Biava's patients, immunofluorescent examicannot serve as a target antigen for circulating antibodies in the human glomerulus as it can in the rat. But megalin nation shows fibrin deposits without immune reactants. In other cases, granular or linear immunoglobulin deposmight be an antigenic component of nephritogenic circulating immune complexes in renal-cancer-associated gloits are seen [15, 18, 19] . One patient with prostatic carcinoma had a crescentic glomerulonephritis with positive merulopathies. Ozawa and associates detected the renal brush-border lipoprotein antigen RTE (an antigenic miximmunoperoxidase staining for both prostate-specific acid phosphatase and prostate-specific antigen, as well ture containing megalin) in glomerular deposits and anti-RTE antibodies in the serum from the same three patients as immune deposits on electron microscopy in the glomerulus [23] . Of particular interest are four patients who [31] , but their findings have not been confirmed yet. Paraneoplastic glomerulopathies theoretically reprepresented with rapidly progressive glomerulonephritis, clinical evidence of vasculitis, and positive ANCA serolsent an attractive model for unraveling the pathogenesis of membranous glomerulonephritis because carcinomas ogy [24] . In all four patients, a carcinoma of either the respiratory or urinary tract was diagnosed soon after the are important sources of antigens that can prompt the production of specific antibodies. Both tumor antigens finding of ANCAs, suggesting the paraneoplastic nature of the vasculitic process. and the respective antibodies can associate in blood as immune complexes, which can subsequently deposit in Membranoproliferative glomerulonephritis and minimal change disease also occur in patients with carcinoma, tissues including the kidney; alternatively, tumor antigens with high affinity for basement membrane constitalthough these lesions are more typical of lymphoproliferative disorders; MPGN has been reported in patients uents can become planted into the glomerular capillary wall, and then participate in in-situ formation of immune with Wilms' tumor and malignant melanoma [25] . Minimal change disease has been associated with a variety of complexes with free circulating antibodies. Numerous attempts have been made to identify tumor antigens or carcinomas; although the nephrotic syndrome can remit completely after surgery [26] , the number of observatheir specific antibodies in kidneys of cancer patients. (Table 4) . Tumor antigens impliare known to occur depending on the location and type of cancer, the mutations resulting in production of anticated in the formation of immune deposits have been the carcinoembryonic antigen, prostate-specific antigens, p53 antibodies [39] . the renal antigen RTE, and other unidentified tumor Hemopathy-induced paraneoplastic glomerulopathies products. Tumor antigens and their corresponding antibodies were associated in glomeruli in only seven pa-
The paraneoplastic nature of these renal lesions is easier to establish than are carcinoma-associated glomerulopatients [25, 31, 36, 38] . Four of these patients, however, had only mild glomerular lesions or none at all and no thies because of the higher rate of complete remission of the malignant hemopathy, and because of the molecusubepithelial deposits [31, 38] .
The presence of tumor antigens and their correspondlar link between the hemopathy and the glomerulopathy, often a monoclonal immunoglobulin, which provides a ing antibodies in patients with paraneoplastic glomerulopathies does not mean, however, that they are involved clear pathophysiologic explanation to the renal lesions observed. This distinction is well illustrated by Patients in the initial pathogenetic process leading to the formation of immune deposits. Indeed, these components can be-2 and 3. Hodgkin's disease. The association between Hodgkin's come passively deposited because of increased glomerular permeability to proteins as a result of the initial insult. disease and glomerulopathy is probably the best known of the hemopathy-induced paraneoplastic glomerulopaLet me summarize. As Alpers and Cotran emphasized [21] , although it is likely that cancer-associated membrathies, although in two large series collecting 1,700 Hodgkin's disease patients, only 0.4% of them had MCD and nous glomerulonephritis is immune-complex-mediated, the limitations of the immunologic studies performed, only 0.1% amyloidosis [40, 41] . In a more recent review, Moulin et al [42] have identified approximately 100 rethe high prevalence of circulating immune complexes, and the frequent deposition of non-pathogenetic glomerports of Hodgkin's-disease-associated glomerulopathy, mainly amyloidosis (37%) and MCD (42%) ( Table 5 ). ular immune reactants in patients with cancer have made it difficult to pinpoint tumor-associated antigens as the It must be noted, however, that most case reports of amyloidosis were published before 1970 and occurred primary initiators of glomerular injury. To further analyze the implication of tumor antigens in paraneoplastic late in the course of the disease. The markedly decreased incidence of amyloidosis in Hodgkin's disease is most glomerulopathies, these antigens must be identified at the molecular level, and experimental models must be likely attributable to modern treatment protocols, which induce a rapid remission of the hemopathy. Franklin et developed in animals immunized with a pure molecular species. Alternatively, it is possible that immune pertural identified the type of amyloid deposit as AA [44] . We can assume that most, if not all, cases of amyloidosis bations in cancer patients (that is, their producing antibodies to exogenous or endogenous antigens) make these previously reported were of the AA type because they occurred in late, inflammatory stages of the disease in individuals prone to developing immune-complex nephritis. Among the myriad possible endogenous antigens, the absence of an M-component. At present, the most frequent glomerulopathy is MCD. eases have been greatly facilitated by the development of sensitive techniques for the characterization of circuIn MCD, the nephrotic syndrome usually appears early, revealing the disease in about one-half the cases and somelating, urinary, and membrane immunoglobulin, and by immunohistochemical and ultrastructural studies of renal times even preceding it by several months; it rapidly disappears after effective treatment of Hodgkin's disease, biopsy. Contrary to glomerular lesions observed in plasma cell dyscrasias, which are well identified and usually reeven if corticosteroids are not used; and it usually relapses simultaneously with the hemopathy, generally reported as series, those occurring in CLL have long been reported only as isolated cases. We published in 1992 maining highly responsive to specific treatment for the cancer. Renal manifestations also can occur in patients the first series of 13 cases [46]; I have further reviewed 32 published observations for this Forum, thus establishwith hematologic relapse even if these manifestations were initially absent. Followup of Hodgkin's disease ing the relative prevalence of the various glomerular lesions (Table 5 ). In CLL and related low-grade B-cell therefore should include evaluation for proteinuria. No particular subgroup of Hodgkin's disease patients, with lymphomas, MPGN and MGN are the most frequent glomerulopathies; extracapillary glomerulonephritis is regard to age, gender, or stage of the disease, appears to be more likely to develop MCD. However, MCD rare by comparison with non-Hodgkin's lymphomas. The CLL-associated glomerulopathies generally fulfill seems to be more frequent in "mixed cellularity" forms of Hodgkin's disease [45] .
the three criteria required for the diagnosis of paraneoplastic syndromes. First, they often reveal CLL and, Other glomerulopathies have been described in association with Hodgkin's disease, albeit with lower frequency as in Patient 2, the diagnosis of both diseases is made simultaneously in about 50% of patients. Nephrotic syn- (Table 5 ). Six patients developed extracapillary glomerulonephritis with anti-glomerular-basement-membrane antidrome is present in 85% of patients and is associated with renal failure in 33%. Second, these glomerulopathies are bodies [reviewed in 42]. The pathogenesis of this association remains obscure but could involve the release and highly sensitive to the chemotherapy used to control CLL. It is remarkable that of the nine successfully treated presentation of basement membrane nephritogenic epitopes or an abnormal immune response induced by Hodgpatients (for their hematologic disease) in our series, seven had full remission of their nephrotic syndrome, kin's disease.
Most studies devoted to the pathophysiology of glomerand renal function improved in seven, remaining stable in the two other patients. In five of the nine patients, ular lesions in Hodgkin's disease have focused on MCD. They support the hypothesis that an alteration in T-lymphthese results were obtained with chlorambucil alone, a drug ordinarily not effective in idiopathic MPGN and ocyte function responsible for abnormal lymphokine production increases vascular permeability and leads to the MGN. This finding strongly suggests that improvement of the glomerulopathy was mainly due to control of the nephrotic syndrome. The putative hyperpermeability factor of lymphocytic origin remains unidentified. hematologic disease. Third, a dysproteinemia was detected in about one-half of the patients in whom it was Chronic lymphocytic leukemia (CLL) and related B-cell lymphomas. Studies on glomerulopathies in these dissought. This alteration consisted of a cryoglobulin in nine cases, and of a non-cryoprecipitating M-component in circulating lymphocytes suggested yet undefined physicochemical anomalies of the M-component that lead to eight. Such a high percentage of dysproteinemia contrasts with its low incidence in CLL without renal involveits rapid deposition [52] . They proposed the term "glomerulonephritis with organized microtubular monoment (5% to 10%). These immunologic anomalies provide a link between the B-cell clone responsible for the clonal immunoglobulin deposition" (GOMMID) for this novel CLL-associated paraneoplastic glomerulopathy. hematologic disease and the glomerulopathy.
From a pathophysiologic point of view, patients who Additional cases have been reported in non-Hodgkin's low-grade lymphomas. Finally, in a third group of pahave CLL with renal involvement illustrate the heterogeneity of paraneoplastic glomerulopathies and underline tients presenting with various glomerular lesions (including FSG, crescentic GN, and advanced fibrotic lesions) the necessity for sophisticated immunopathologic analyses to dissect the mechanisms at play. Schematically, paand neither cryoglobulin nor monotypic glomerular deposits, a clear-cut pathophysiologic link between CLL tients can be divided into three groups. The first group includes patients with MPGN caused by cryoglobulinemia, and the glomerulopathy could not be established [46] . Plasma cell dyscrasias. Various types of glomerular dismostly type II. The existence of type-I or type-II cryoglobulinemia is not surprising in a lymphoproliferative eases occur in patients with plasma cell dyscrasias (PCD). These diseases can be classified into two categories by disorder such as CLL, in which the B-lymphocyte clone can be secretory. Cryoglobulins can be considered imelectron microscopy. The first, characterized by organized deposits, includes diseases with fibrillar deposits, mune complexes in which the antigen is a polyclonal immunoglobulin (type-II or type-III cryoglobulin) or remainly amyloid light-chain (AL) amyloidosis, and diseases with microtubule formation such as cryoglobulimains of undetermined nature (type-I cryoglobulin). In the case of type-II and type-III cryoglobulins, the polynemic glomerulonephritis. The second category, which mostly includes MIDD, is defined by non-organized declonal immunoglobulin itself is endowed with antibody activity that is most often not identified. Gilboa et al posits usually exhibiting a granular appearance. The most frequent glomerulopathy in PCD is AL amyloidosis, made an interesting observation in two patients with CLL associated with MPGN, hypocomplementemia, and type-I found in about 11% of myeloma patients at autopsy [55] . Amyloid light-chain amyloidosis fulfills the criteria of a cryoglobulinemia composed of an IgG M-component [50] . Their finding that immunoglobulin eluted from both truly paraneoplastic disease: it often reveals the PCD; the precursor of amyloid fibrils is the light chain, mostly the glomeruli and the serum cryoglobulin bound in vitro to patients' glomeruli but not to normal glomeruli sug-, produced by the plasma cell clone; and regression of amyloid deposits can be observed when the secreting gested that the monoclonal IgG was directed to nonglomerular antigens. The latter might be lymphocyte clone is eradicated, mainly by intensive chemotherapy with the support of syngeneic bone-marrow transplantaantigens as suggested by Day and colleagues [51] or nonlymphocyte antigens, including viral antigens. On the tion or blood stem-cell autografting [56]. I will not detail the characteristics of amyloidosis because it is a wellother hand, because of cryoglobulin's ability to precipitate in vessels under certain circumstances, we also known entity [reviewed in 57, 58]. It has been known since the late 1950s that nonamyshould suspect a direct pathogenetic role for it, irrespective of cryoglobulin composition. loidotic forms of glomerular disease resembling the lesion of diabetic glomerulosclerosis also could occur in The second group, to which Patient 2 belongs, is characterized by monotypic immunoglobulin deposits in the multiple myeloma. The presence of monoclonal light chains in these lesions was recognized later by Randall absence of cryoglobulinemia, with or without a circulating M-component. Some of these patients present with feaet al, who published the first description of light-chain deposition disease (LCDD) [59] . The finding of both tures typical of monoclonal immunoglobulin-deposition disease (MIDD) with nodular glomerulosclerosis stained monoclonal heavy chains and light chains in the tissue deposits from some patients defined light-and heavywith the anti-or anti-light-chain antibody [47] . Others have an atypical form of MGN, usually with thick, fibrilchain deposition disease (LHCDD). More recently, deposits containing monoclonal heavy chains only (HCDD), lary deposits seen on electron microscopy [52, 53]. The microtubular aspect of the deposits and the absence of that is, in the absence of detectable light chains, were observed in patients with otherwise typical Randall's tubular basement membrane staining with anti-lightchain antibodies distinguish these cases from MIDD, in disease [60] . In clinical and pathologic terms, LCDD, LHCDD, and HCDD are basically similar and are therewhich the deposits display a granular pattern; instead these alterations recall the ultrastructural lesions defore also referred to as monoclonal immunoglobulin deposition disease. They differ from amyloidosis by their scribed in immunotactoid glomerulopathy. Korbet et al reported one patient with immunotactoid glomerulopalack of affinity for Congo red stain and by the lack of fibrillar organization of the deposits, which usually disthy and CLL [54] . Touchard and associates' finding of organized microtubular structures in the cytoplasm of play a granular appearance on electron microscopy. An Table 6 from the four largest series yet published Predominant isotype [63] [64] [65] [66] . underlying disease is myeloma, which accounts for 40% to 50% of LCDD and 25% of HCDD. Autopsy revealed MIDD in about 5% of myeloma patients [55] . Other malignancies occasionally involved are CLL and WalIn our patient as well as in the 6 others [68] in whom a denströ m's macroglobulinemia. Like AL amyloidosis, structural analysis of the heavy chain was performed MIDD also can occur in the absence of a detectable either by epitope mapping of the constant domains of the malignant process, even after prolonged follow up circulating or the deposited heavy chain or by sequence (longer than 10 years). This finding illustrates that the analysis [69] , a deletion of the first constant domain C H 1 same disease can be induced by a light chain produced was observed. In the blood the deleted heavy chain was by either a malignant or a benign plasma-cell clone; thus associated with light chains, mostly of the isotype, or paraneoplastic-like glomerulopathies can occur with becirculated in small amounts as a free unassembled subnign proliferation. At least two retrospective studies unit. Since the retention of free heavy chains in the have shown the potential renal benefits of chemotherapy endoplasmic reticulum before their association with light [66, 67] although, as for amyloidosis, regression of lightchains requires binding of chaperone proteins to the C H 1 chain deposits is rarely observed.
domain, we can deduce that the C H 1 deletion facilitates Monoclonal immunoglobulin-deposition disease prothe secretion of free unassembled or partially assembled vides a unique opportunity for analysis of the pathogeneheavy chains that are rapidly cleared from the circulation sis of some paraneoplastic glomerulopathies at the moby organ deposition. Although deletion of the C H 1 seems lecular level, because the nephritogenic molecule is a to be necessary for the development of HCDD, the delemonoclonal immunoglobulin subunit. In LCDD, several tion is not sufficient. Similar deletions indeed are found characteristics of light chains might partially explain their in heavy-chain disease, a lymphoproliferative disorder pathogenicity [reviewed in 58]. Table 7 compares these in which renal tissue deposition of the truncated heavy characteristics with those of amyloidogenic light chains, chains has not yet been documented, and in AH amybecause different physicochemical properties of these loidosis, in which deposits have a fibrillar organization molecules are likely responsible for the granular (in [69] . These data suggest that the variable domain of the MIDD) or fibrillar (in amyloidosis) aspect of the deposits heavy chain (V H ) is also required for tissue precipitation. [reviewed in 58].
Although a monoclonal component usually represents Patient 3, who had myeloma-induced HCDD, shows the molecular link between the plasma cell proliferation that a detailed analysis of the serum and the renal biopsy and the glomerulopathy in PCD, there are puzzling exwith specific anti-constant domain antibodies can proceptions characterized by the occurrence of severe glomerulonephritis in the absence of M-component deposivide further insight into the pathogenesis of the disease.
tion. The best example is the glomerulopathy of POEMS could identify the molecular link. In particular, this would allow us to dispel the doubts cast by several authors on syndrome, also called Crow-Fukase syndrome, a multisystemic disorder characterized by polyneuropathy, orthe truly paraneoplastic nature of these glomerulopathies, and to better delineate the risk of inducing renal disease ganomegaly, endocrinopathy, monoclonal protein, and skin changes [70] . A variety of glomerular alterations in cancer patients treated by antitumor vaccination. have been described, including MPGN-like, microangiopathic, and mesangiolytic lesions, but without deposition QUESTIONS AND ANSWERS of the M-component [71] . In the forms with a localized Dr. John T. Harrington (Dean, Tufts University plasmacytoma, removal of the tumor induced dramatic School of Medicine, Boston, Massachusetts): The comimprovement of the clinical manifestations. The role of mon theme in all these patients is proteinuria secondary growth factors, including interleukin-6 and vEGF [72, to increased glomerular permeability. Could you specu-73], has been proposed to explain endothelial proliferalate on the lymphokines that might be involved? Second, tion and associated vascular lesions. POEMS-related glohave serum or cells from patients with Hodgkin's disease merulopathies share common features with Castleman's and MCD been shown in experimental tissue systems to disease, a lymphoproliferative and vascular disorder that increase basement membrane permeability? is sometimes associated with POEMS syndrome. The Dr. Ronco: The most appropriate neoplasia for disfinding of human herpesvirus-8 (HHV-8) in about 40%
cussing the role of lymphokines as permeability factors of non-HIV patients with Castleman's disease [74] and is à priori Hodgkin's disease because proteinuria usually the angiogenesis-activating properties of HHV-8, the occurs in the absence of glomerular lesions and also Kaposi's sarcoma-associated herpesvirus (KSHV) [75] , because lymphokines have been involved in several mansuggest that HHV-8/KSHV is implicated in the pathoifestations of the disease. However, the view that Hodgphysiology of vascular lesions.
kin and Reed-Sternberg cells, which both have been
Non-Hodgkin's lymphoma (NHL). Patients with NHL
assigned to the B-cell compartment [76] , increase glomanifest a great variety of glomerular lesions (Table 5) merular permeability via the secretion of a single lym- [49] . Contrary to the observations made in Hodgkin's phokine is far too simplistic. First, Hodgkin and Reeddisease, MCD is rare in NHL; the most frequent glomerSternberg cells usually make up less than 1% of the ulopathies are MPGN and crescentic glomerulonephritis.
tumor cell mass, which is mainly composed of a polymorBecause of the diversity of renal lesions, an important phic cellular infiltrate comprising T-cells, eosinophils, question is whether the association between NHL and neutrophils, plasma cells, histiocytes, and fibroblasts in glomerulonephritis is coincidental. As for CLL, a clear-cut close vicinity to the malignant cells. Second, a great varirelationship can be established in patients with cryoglobety of lymphokines and growth factors (IL-1, IL-2, IL-4, ulinemic MPGN and in those with immunotactoid glomer-IL-6, IL-7, IL-9, IL-12, TNF, lymphotoxin-␣, INF-␥, GMulonephritis with monotypic immunoglobulin deposits. CSF, etc.) are produced both by infiltrating and tumor Conclusion cells [76] . These cytokines can act locally to support growth of Hodgkin and Reed-Sternberg cells and systemThe spectrum of paraneoplastic glomerulopathies has ically as immune or pro-inflammatory mediators. Susdramatically expanded with the description of glomerutained secretion of IL-1, IL-6, and TNF most likely aclar complications of CLL and plasma cell dyscrasias. The counts for increased liver production of SAA and the occurrence of similar glomerular lesions in benign and development of AA-type amyloidosis in the few patients in malignant lymphocyte or plasma-cell proliferations with uncontrolled Hodgkin's disease. In contrast, it is as underlines the pathogenetic role of the secreted moleyet impossible to tell which cell type and which lymphocule, mostly an immunoglobulin, irrespective of the makine are responsible for MCD. It seems likely, however, lignant or benign nature of the cell proliferation. In fact, that proteinuria is caused by infiltrating activated T-cells in plasma cell dyscrasias, malignancy may be conferred rather than by tumor cells. by the severity of visceral manifestations due to lightWith regard to your second question, one approach chain deposition rather than by the cytologic features of to the identification of the permeability factor produced the proliferating clone. Thus, not only have hemopathyin some patients with Hodgkin's disease would involve induced glomerular diseases markedly broadened our testing the glomerular effects of pure or fractionated knowledge of paraneoplastic glomerulopathy, they also serum and cells (or cell supernatants) on basement memhave permitted us to bridge the gap at the molecular level brane permeability. To my knowledge, only one report between the cellular proliferation and the nephropathy.
addressed this important question [77] . Glomerular perThe clinician now has a valid reason to treat and reason meability did not increase in any rats or mice injected to hope for improvement of the glomerulopathy.
or perfused with serum or cell-culture supernatants from In contrast, carcinoma-associated glomerulopathies still raise a number of questions that could be solved if we a patient with Hodgkin's disease and MCD. Moreover, xenografts containing T-cells from this patient did not ative disorders. The fact that the molecular link, which usually is a monoclonal immunoglobulin, is known in induce proteinuria or glomerular changes in tolerant mice. Thus, the attractive hypothesis of a disorder of T-cell the latter glomerulopathies does not rule out that they are paraneoplastic. Nor will this adjective become inapfunction in MCD, which was put forward by Shalhoub 25 years ago [78], has not yet been supported at the propriate when the putative lymphokine(s) involved in Hodgkin's disease-associated MCD or the antigen remolecular level despite an increasing knowledge of alterations of the cytokine network in Hodgkin's disease [76] .
leased by tumor cells in carcinoma-associated MGN are identified. In this respect, one of the most characteristic Dr. Harrington: Are there any good animal models for paraneoplastic glomerulopathies?
paraneoplastic syndromes is Schwartz-Bartter syndrome, which occurs in small-cell lung carcinomas producing Dr. Ronco: I am not aware of any animal model for carcinoma-associated glomerulopathy. The development arginine vasopressin. I do admit, however, that the classification of myeloma cast nephropathy is difficult because of such a model would require grafting of carcinoma cells from patients with paraneoplastic glomerulopathy this disease, caused by light-chain precipitation in distal tubule lumens, occurs almost exclusively in myeloma to immunodeficient mice. However, animals can die before developing proteinuria. The lack of progress in the patients with high tumor burdens [80] . Finally, I fully agree that renal manifestations in AL amyloidosis and pathophysiology of MGN in humans seems to have discouraged research in the field of paraneoplastic MGN.
LCDD patients mainly depend on abnormalities of immunoglobulin chains that are unrelated to malignancy. It is much easier to inject mice with plasma cells producing a nephritogenic immunoglobulin. An animal model Thus the same renal disease can be observed in malignant and nonmalignant conditions provided they share of MIDD has thus been established [79] . It allowed identification of the role of amino acid substitutions in the same molecular link. ance of proteinuria and other renal symptoms after removal of the tumor. You said that a second renal biopsy nothing to add to the very nice and thorough discussion by Dr. Ronco, I would like to make a comment. The at the time of complete remission is usually not performed for ethical reasons. Are you aware of case reports term "paraneoplastic" appears to be both inappropriate and confusing. It lumps together completely unrelated demonstrating histologic remission of the renal disease? Dr. Ronco: I know about one report of complete processes, the rather poorly understood lesions observed in carcinomas and Hodgkin's lymphoma, on the one histologic remission of MGN after resection of an adenocarcinoma of the ascending colon [81] . Kidney tissue was hand, in which the renal disease is indeed paraneoplastic, and lesions directly linked to monoclonal immunoglobuavailable seven years after remission of the nephrotic syndrome because a left nephroureterectomy was done lins in immunoproliferative disorders, on the other hand. In the latter conditions, if the underlying hematologic after detection of a renal cell cancer. No evidence of MGN was found by light microscopy, immunofluorescondition is malignant, the renal lesion relates to an intrinsic and major function of the proliferating cells and cence, and electron microscopy. I should stress, however, that remission of the nephrotic syndrome occurred about the relationship is direct and not lateral or indirect, as "para" means. Do you call myeloma cast nephropathy one year after removal of the tumor and that the patient received high-dose steroids for several months. paraneoplastic? More important, the overtly malignant or apparently benign condition of the hemopathy is irrelDr. Maurice Laville (Département de Néphrologie, Hô pital Edouard-Herriot, Lyon, France): Both maligevant. Two-thirds of AL amyloidosis and one-third of LCDD patients have no malignant disease, and yet the nant and nonmalignant lymphoid tissue proliferations can be associated with paraneoplastic glomerulopathies. visceral lesions are the same as those in patients with myeloma. The causes of the disease are molecular abnorDo you think that the lymphoid tissue reaction to carcinoma rather than the release of tumor antigens is responmalities of immunoglobulin chains that are unrelated to malignancy.
sible for the development of proteinuria and glomerular lesions? Dr. Ronco: I agree that the term "paraneoplastic" is ambiguous in some instances. As I specified in my discus- Although Patient 3 with ␥1-HCDD had normal completribute to the pathogenesis of paraneoplastic syndromes. In my own experience of patients with diffuse monoment levels, signs of complement consumption were found in three of four patients with ␥1-HCDD, in all clonal proliferation of CD8 T-cells and neutropenia, removal of a large tumor-for instance, splenectomy-is three patients with ␥3-HCDD, and in none of the two patients with ␥4-HCDD as yet reported [reviewed in 68] . often associated with a dramatic increase of the neutrophil polymorphonuclear cell count.
The lack of complement activation in patients with ␥4-HCDD is not surprising since ␥4 does not activate comDr. Ronco: Because our first patient also received three courses of chemotherapy after surgery, it is difficult plement. Two regions play a critical role in complement activation: the C H 2 that expresses the C1q binding site, to establish whether the absence of renal relapse was accounted for by chemotherapy or by the lower tumor and the hinge region that confers flexibility to the immunoglobulin molecule [84] . I should stress that deletion mass of mediastinal lymph nodes. I agree that full-blown expression of paraneoplastic glomerulopathies can indiof the C H 1 was found in all seven patients in whom this anomaly was sought [68] . I am aware of two additional rectly be linked to tumor burden in carcinoma patients.
Dr with POEMS syndrome. Four of these patients also had weight loss, asthenia) and signs of inflammatory activity, Castleman's disease. Anti-HHV-8 antibodies could be both being caused by the lymph node lesion; all sympdetected in only one of the 13 patients, who did not have toms and signs disappear after surgical excision or sucCastleman's disease (Papo T, unpublished data). We also cessful medical treatment of the mass.
found very high serum levels of vEGF in eight patients Recent data indeed suggest that excessive IL-6 prowith POEMS syndrome; however, vEGF levels were simduction by plasma cells and cells of the germinal centers ilar in patients with (n ϭ 4) and without (n ϭ 4) renal play a role in the genesis of systemic and renal manifestainvolvement [96] . tions of Castleman's disease [86] . Renal complications Dr. Clauvel: The lack of antibodies in some series of include AA-type amyloidosis, MPGN, thrombotic mipatients with Castleman's disease does not exclude HHV-8 croangiopathy, and acute interstitial nephritis (Kazes I, infection. In our own series, antibodies were detected in unpublished data). Reversal of nephrotic syndrome due 90% of the patients. Such discrepant results could be to AA-type amyloidosis [89] and resolution of MPGN explained by technical problems. Anti-HHV-8 antibodies [90] were observed after excision of a giant axillary lymph also have been detected in myeloma patients [97] . The node and prednisolone and cyclophosphamide therapy, absence of these antibodies could be due to the small respectively. Relapse of Castleman's disease occurred numbers of dendritic cells infected with HHV-8 and to with increasing proteinuria [90] . Most likely, IL-6 is an the low copy number of virus in any individual cell [98] . important molecular link between the lymphoproliferaDr. Cordonnier: In your second patient with CLLtive disorder and glomerular lesions because IL-6 inrelated glomerulopathy, subepithelial deposits had a ficreases SAA protein synthesis by hepatocytes [91] and brillary structure made of microtubules with a diameter increases mesangial cell proliferation and matrix producof 22 nm. The size and structure are reminiscent of those tion in vivo [87]. Castleman's disease-associated glomerof IgG described in monoclonal cryoprecipitates by our ulopathies thus fulfill all the criteria for paraneoplastic group in 1979 [99] . I would suggest that the link between glomerulopathies although the underlying hemopathy the few blood cells that showed cytoplasmic spots of ␥ and often is benign.
chains and the renal deposits could have been a transient The detection of HHV-8/KSHV in 40% of HIV-negacryoglobulin inducing complement consumption. tive patients with Castleman's disease [74] and the demDr. Ronco: Although the hypothesis of a transient onstration of viral genes encoding vIL-6, Bcl-2, and cyclins cryoglobulinemia cannot be ruled out completely, the [92] led to the suggestion that the virus could be implirenal lesions were not suggestive of a cryoglobulinemic cated both in B-cell proliferation and in systemic and kidney mainly because there was no subendothelial derenal manifestations of Castleman's disease. In addition, posit. In fact, the renal lesions were similar to those the tropism of HHV-8/KSHV for endothelial cells [93] found in GOMMID [52] . and its angiogenic effects mediated by a G-protein-couDr. Guy Touchard (Service de Néphrologie, Univerpled receptor and vEGF secretion [74] might account sity Hospital, Poitiers): Patient 2 is affected with the condition we have described as GOMMID in every asfor the development of vascular lesions that occur in pect, including response to chemotherapy [52] . This enlate on the mechanisms responsible for this accumulation of extracellular matrix? tity was diagnosed in five of our six patients presenting Dr. Ronco: Zhu and associates have shown that prowith the nephrotic syndrome associated with CLL. The duction of matrix proteins (including type-IV collagen, sixth patient also had organized microtubular immunolaminin, and fibronectin) and of bioactive TGF-␤ was globulin deposits, but these deposits were not monotypic, increased in rat mesangial cells cultured in the presence as they contained ␥, , , and chains. Also, GOMMID of light chains isolated from MIDD patients [101] . Furwas found in one patient with a benign monoclonal gamthermore, anti-TGF-␤ antibody abolished the inhibition mopathy (MGUS) and in three patients without overt of cell proliferation and the increase of extracellular maplasma cell dyscrasia. We could not detect the deposited trix protein production caused by these light chains. M-component in the serum and the urine even by the These findings were not obtained when mesangial cells sensitive Western blotting method in two of five patients were exposed to human albumin or to two other light with GOMMID and CLL and in two of four patients chains previously characterized to be tubulopathic. Towith GOMMID not linked with CLL.
gether with overexpression of TGF-␤ in affected glomerDr. Preud'homme: One may regret that in Patient 2, uli of MIDD patients, these data support a key role for circulating M-components were not sought by Western TGF-␤ in extracellular matrix accumulation. blotting, which is more sensitive than immunofixation Dr. Rossert: If TGF-␤ is a key player, would you not by several orders of magnitude. In addition, cytoplasmic expect some accumulation of type-I collagen? immunofluorescence and electron microscopic studies of Dr. Ronco: Certainly, yes. I should stress, however, the lymphocytes could have provided evidence of a direct that matrix accumulation can result from increased synrelationship between CLL and renal deposits.
thesis but also from decreased degradation of matrix Dr. Ronco: Patient 2 was referred to us several years components. Since type-I and type-IV collagens are deago, before Western blotting was commonly used as a graded by different metalloproteases, one could suggest sensitive method for detecting M-components. We could that those degrading type-I collagen (interstitial collanot identify with certainty whether the cytoplasmic spots genases) are upregulated in glomeruli of MIDD patients. of ␥ and chains were localized in lymphocytes; neither Dr. Preud'homme: Nodular glomerulosclerosis is obcould we detect organized deposits in lymphocytes by served in 100% of HCDD, approximately 60% of LCDD, electron microscopy because of the small number of cirand very few LCDD cases. I would be most interested culating lymphocytes during chemotherapy.
in the interpretation of these apparently isotype-related Dr. Touchard: Concerning the classification of grandifferences by our nephrologist colleagues. ular (non-organized) monoclonal immunoglobulin deDr. Ronco: A first explanation is that the duration posits, it seems important to distinguish two types of of the underlying hematologic disease may be longer in deposits according to their localization: Randall-type patients who develop nodular glomerulosclerosis. This granular deposits affecting glomerular and tubular basehypothesis is supported by the apparently lower prevament membranes, and non-Randall-type granular deposlence of myeloma in HCDD than in LCDD patients. its affecting the subepithelial and subendothelial spaces Second, the fibrogenetic potential might depend on the of glomerular capillary wall and often the mesangium isotype and surface properties of the M-component. The but not the peritubular area. We recently studied a patient mesangial cell most likely is the main culprit of extracelwith type-III MPGN and granular non-Randall-type monolular matrix accumulation. Because the pattern of inclonal light-chain dense deposits in mesangial, subcreased matrix components is similar to that observed epithelial, and intramembranous areas. The monoclonal in diabetes and also because 20% to 30% of light chains light chain activated the alternative pathway of compleisolated from MIDD patients are glycosylated, it has ment, probably by interacting directly with factor H as been suggested that fibrogenetic light chains could bind previously reported [100] . Certainly LCDD, HCDD, and to mesangial cells via the receptor for advanced glycosyl-LHCDD are the most frequent forms of MIDD, but ation end products (AGEs) and thereby increase matrix there is still room for other variants of the disease.
protein production through PDGF [102] . The varying Dr. Ronco: We also have encountered cases of MIDD fibrogenetic potential of light and heavy chains might be with non-organized granular deposits restricted to the accounted for by different abilities of the M-component glomerulus. I agree that MIDD can be more heterogeto bind mesangial cell receptors and to trigger intracelluneous than expected. Patients with MIDD should be lar pathways, leading to increased transcription of some classified according to the type of deposited M-component matrix protein genes. and to the precise location of the deposits.
Dr. Bruno Moulin (Service de Néphrologie, Hô pital Dr. Rossert: During the course of MIDD, there is Civil, Strasbourg, France): As you stated, MIDD is a deposition of a monoclonal component but also a striking systemic, life-threatening disease whether it occurs in the setting of a benign or a malignant plasma cell proliferaccumulation of extracellular matrix. Could you specu-
